Results 131 to 140 of about 324,947 (241)

The epithelial–mesenchymal transition (EMT) phenomenon

Annals of Oncology, 2010
The epithelial-mesenchymal transition (EMT) describes a rapid and often reversible modulation of phenotype by epithelial cells. EMT was originally defined in the context of developmental stages, including heart morphogenesis, mesoderm and neural crest formation. Epithelial cells loosen cell-cell adhesion structures throughout EMT.
openaire   +3 more sources

N-Cadherin Expression and Epithelial-Mesenchymal Transition in Pancreatic Carcinoma [PDF]

, 2004
Sanae Nakajima, Ryuichiro Doi, Eiji Toyoda, Shoichiro Tsuji, Michihiko Wada, Masayuki Koizumi, Sidhartha Tulachan, Daisuke Ito, Kazuhiro Kami, Tomohiko Mori, Yoshiya Kawaguchi, Koji Fujimoto, Ryo Hosotani, Masayuki Imamura   +13 more
openalex   +1 more source

N6-methyladenosine modification and post-translational modification of epithelial–mesenchymal transition in colorectal cancer

Discover Oncology
Colorectal cancer is a leading cause of cancer-related mortality worldwide. Traditionally, colorectal cancer has been recognized as a disease caused by genetic mutations.
Yingnan Wang, Yufan Chen, Miaomiao Zhao
doaj   +1 more source

Epithelial-mesenchymal transition in glioblastoma progression

Oncology Letters, 2016
Epithelial-mesenchymal transition (EMT) is a reversible biological process that occurs in epithelial cells. EMT ultimately leads to the acquisition of a mesenchymal phenotype, characterized by increased cell motility and resistance to genotoxic agents.
openaire   +4 more sources

Transient Overexpression of TGF-β1 Induces Epithelial Mesenchymal Transition in the Rodent Peritoneum [PDF]

, 2004
Peter J. Margetts, Philippe Bonniaud, Limin Liu, Catherine M. Hoff, Clifford J. Holmes, Judith A. West‐Mays, Margaret M. Kelly   +6 more
openalex   +1 more source

SnapShot: The Epithelial-Mesenchymal Transition

Cell, 2011
Sleeman, J. P., Thiery, J. P.
openaire   +4 more sources

Epithelial-Mesenchymal Transition: NF-κB Takes Center Stage [PDF]

, 2004
Margit A. Huber, Hartmut Beug, Thomas Wirth   +2 more
openalex   +1 more source

Tumor Metastasis: A New Twist on Epithelial–Mesenchymal Transitions [PDF]

, 2004
Ann E. Vernon, Carole LaBonne
openalex   +1 more source

An angiotensin system inhibitor (losartan) potentiates antitumor efficacy of cisplatin in a murine model of non–small cell lung cancerCentral MessagePerspective

JTCVS Open
Objective: Previous studies have demonstrated synergistic antitumor effects of angiotensin system inhibition (ASI) combined with cisplatin therapy in pancreatic cancer.
Hexiao Tang, MD, PhD, Eric Abston, MD, PhD, Mozhdeh Sojoodi, PhD, Yongtao Wang, PhD, Derek J. Erstad, MD, Zenan Lin, MD, Bryan C. Fuchs, PhD, Kenneth K. Tanabe, MD, Michael Lanuti, MD   +8 more
doaj  

Pediatric cancer—pathology and microenvironment influence: a perspective into osteosarcoma and non-osteogenic mesenchymal malignant neoplasms

Discover Oncology
Pediatric cancer remains the leading cause of disease-related death among children aged 1–14 years. A few risk factors have been conclusively identified, including exposure to pesticides, high-dose radiation, and specific genetic syndromes, but the ...
Consolato M. Sergi
doaj   +1 more source